Close

Amylin (AMLN), Takeda Suspend Obesity Treatment Trial; Amylin Lower Pre-Market

March 16, 2011 8:06 AM EDT Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited have suspended clinical activities in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login